Molecular sensitisation patterns to aeroallergens in a Mediterranean paediatric population and their clinical implications
Main Article Content
Keywords
exposome, molecular diagnosis, paediatric population, polysensitisation, precision medicine
Abstract
Background: Environmental exposures, climate change, and lifestyle factors are key contributors to respiratory allergies. Understanding the connection between allergen exposure and the development of allergic diseases in early life is essential for identifying sensitization patterns and optimizing diagnostic and therapeutic strategies.
Objective: This study aims to characterize the allergic sensitization profile in a Mediterranean paediatric population using a component-resolved diagnosis (CRD) approach. Specifically, we analyse the prevalence and serodominance of aeroallergens, examine age-related sensitization patterns, and assess their implications for personalized allergen immunotherapy. Additionally, we highlight the need to incorporate the identified molecular allergens into standardized allergenic extracts to improve diagnostic accuracy and immunotherapy efficacy.
Methods: We conducted an observational, cross-sectional study including paediatric patients (0–15 years) diagnosed with allergic rhinitis, with or without asthma. Patients were classified according to disease severity following international guidelines. Skin prick tests were performed using standardized extracts, and specific IgE levels were determined with the multiplex assay Allergy Explorer 2 (ALEX2-MADX).
Results: A total of 47 patients were included (mean age: 7.5 years). Sensitization to house dust mites (HDM) was the most prevalent (74.5%), followed by pollen (57.4%) and animal epithelia (44.6%). The most frequently recognized allergens were Der p 23 (59.57%) for HDM, Ole e 1 (36.17%) for olive pollen, and Fel d 1 (27.7%) for cat epithelium. The highest IgE levels were observed in children aged 6–10 years. Polysensitization was present in 66% of patients, with frequent co-recognition of allergens from different sources. The findings emphasize the need to ensure that allergenic extracts used in diagnosis and immunotherapy contain relevant molecular components to enhance treatment precision.
Conclusion: A detailed molecular characterization of allergic sensitization in paediatric patients provides valuable insights into aeroallergen exposure and its clinical implications. Our findings reinforce the importance of incorporating relevant molecular allergens into standardized diagnostic and therapeutic extracts to optimize patient management and improve the efficacy of allergen-specific immunotherapy.
References
2 Muddaluru V, Valenta R, Vrtala S, Schlederer T, Hindley J, Hickey P, et al. Comparison of house dust mite sensitization profiles in allergic adults from Canada, Europe, South Africa and USA. Allergy. 2021;76(7):2177–88. 10.1111/all.14749
3 Yuriev S, Rodinkova V, Mokin V, Varchuk I, Sharikadze O, Marushko Y, et al. Molecular sensitization pattern to house dust mites is formed from the first years of life and includes group 1, 2, Der p 23, Der p 5, Der p 7 and Der p 21 allergens. Clin Mol Allergy. 2023;21(1):1. 10.1186/s12948-022-00182-z
4 Lopez-Rodriguez R, Rial MJ, Esteban-Gorgojo I, Veleiro Perez B, Lopez-Araujo GA, Perez-Quintero O, et al. Serodominance Profile in a Dust Mite Complex Region. Int Arch Allergy Immunol. 2022;183(8):843–51. 10.1159/000523869
5 Ridolo E, Incorvaia C, Heffler E, Cavaliere C, Paoletti G, Canonica GW. The Present and Future of Allergen Immunotherapy in Personalized Medicine. Journal of Personalized Medicine. 2022; 12(5):774. 10.3390/jpm12050774
6 Passalacqua G, Canonica GW. AIT (allergen immunotherapy): a model for the “precision medicine”. Clin Mol Allergy. 2015;13:24. 10.1186/s12948-015-0028-6
7 Izmailovich M, Semenova Y, Abdushukurova G, Mukhamejanova A, Dyussupova A, Faizova R, et al. Molecular Aspects of Allergen-Specific Immunotherapy in Patients with Seasonal Allergic Rhinitis. Cells. 2023;12(3). 10.3390/cells12030383
8 Plaza V, Blanco M, Garcia G, Korta J, Molina J, Quirce S, et al. Highlights of the Spanish Asthma Guidelines (GEMA), version 5.0. Arch Bronconeumol (Engl Ed). 2021;57(1):11–2. 10.1016/j.arbres.2020.10.003
9 Brozek JL, Bousquet J, Agache I, Agarwal A, Bachert C, Bosnic-Anticevich S, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 revision. J Allergy Clin Immunol. 2017;140(4):950–8. 10.1016/j.jaci.2017.03.050
10 Moral L, Roig M, Garde J, Alós A, Toral T, Fuentes MJ. Allergen sensitization in children with asthma and rhinitis: marked variations related to age and microgeographical factors. Allergol Immunopathol (Madr). 2008;36(3):128–133. 10.1157/13124718
11 Limao R, Spinola Santos A, Araujo L, Cosme J, Inacio F, Tomaz E, et al. Molecular Profile of Sensitization to Dermatophagoides pteronyssinus Dust Mite in Portugal. J Investig Allergol Clin Immunol. 2021;32(1):33–9. 10.18176/jiaci.0533
12 Vidal C, Lojo S, Juangorena M, Gonzalez-Quintela A. Association Between Asthma and Sensitization to Allergens of Dermatophagoides pteronyssinus. J Investig Allergol Clin Immunol. 2016;26(5):304–9. 10.18176/jiaci.0048
13 Stranzl T, Ipsen H, Christensen LH, Eiwegger T, Johansen N, Lund K, et al. Limited impact of Der p 23 IgE on treatment outcomes in tablet allergy immunotherapy phase III study. Allergy. 2021;76(4):1235–8. 10.1111/all.14200
14 Gonzalez-Perez R, El-Qutob D, Letran A, Matheu V. Precision Medicine in Mite Allergic Rhinitis. Front Allergy. 2021;2:724727 . 10.3389/falgy.2021.724727
15 Matricardi PM, Dramburg S, Potapova E, Skevaki C, Renz H. Molecular diagnosis for allergen immunotherapy. J Allergy Clin Immunol. 2019;143(3):831–43. 10.1016/j.jaci.2018.12.1021
16 Dramburg S, Hilger C, Santos AF, de Las Vecillas L, Aalberse RC, Acevedo N, et al. EAACI Molecular Allergology User’s Guide 2.0. Pediatr Allergy Immunol. 2023;34 Suppl 28:e13854.
17 Cipriani F, Tripodi S, Panetta V, Perna S, Potapova E, Dondi A, et al. Early molecular biomarkers predicting the evolution of allergic rhinitis and its comorbidities: A longitudinal multicenter study of a patient cohort. Pediatr Allergy Immunol. 2019;30(3):325–34. 10.1111/pai.13036
18 Grabenhenrich LB, Keil T, Reich A, et al. Prediction and prevention of allergic rhinitis: A birth cohort study of 20 years. J Allergy Clin Immunol. 2015;136(4):932–40. 10.1016/j.jaci.2015.03.040
19 Dramburg S, Hilger C, Santos AF, et al. EAACI Molecular Allergology User’s Guide 2.0. Pediatr Allergy Immunol. 2023;34 Suppl 28:e13854. 10.1111/pai.13854
20 Spanish Society of Allergology and Clinical Immunology. Allergológica 2015. In Spanish Society of Allergology and Clinical Immunology.
21 Lopez Couso VP, Tortajada-Girbes M, Rodriguez Gil D, Martinez Quesada J, Palacios Pelaez R. Fungi Sensitization in Spain: Importance of the Alternaria alternata Species and Its Major Allergen Alt a 1 in the Allergenicity. J Fungi (Basel). 2021;7(8). 10.3390/jof7080631
